ADIPOQ and type 1 diabetes mellitus: Furthermore, genetic variants linked to insulin signaling and glucose metabolism—such as polymorphisms in INSR, PPARG, and ADIPOQ—have been associated with increased susceptibility to IR, suggesting a complex interplay between autoimmune and metabolic genetic predispositions in some patients with T1D (17).